客製化合成基因服务市场：依产品、技术、基因类型、最终用户和应用划分－2026-2032年全球预测

预计到 2025 年，客製化合成基因服务市场价值将达到 7.961 亿美元，到 2026 年将成长至 8.8319 亿美元，到 2032 年将达到 17.2984 亿美元，复合年增长率为 11.72%。

关键市场统计数据
基准年 2025	7.961亿美元
预计年份：2026年	8.8319亿美元
预测年份 2032	17.2984亿美元
复合年增长率 (%)	11.72%

客製化合成基因服务的策略实施：重点阐述科学基础、市场驱动因素、法规环境与策略重点

本执行摘要概述了客製化合成基因服务的现状，整合了支撑产业决策的科学、商业性和监管背景。它帮助读者了解复杂的行业环境，在这个环境中，DNA合成、基因构建和基因编辑技术的进步与不断演变的采购惯例以及日益严格的管理体制审查相互交织。它重点阐述了当前市场环境中机会与营运风险并存的双重特征，这种特征对服务提供者、最终用户和投资者都至关重要。

快速的技术进步、供应链弹性措施以及不断变化的监管重点将如何重塑客製化合成基因生态系统？

客製化合成基因服务领域正经历快速而变革性的转变，这主要得益于技术突破和营运模式的调整。 DNA合成技术的进步、更精准的基因建构技术以及不断扩展的基因编辑工具包，使得设计週期得以缩短，建构的基因也更加复杂，从而为研发和治疗开发创造了新的可能性。同时，供应链压力和试剂来源的变化迫使服务供应商和终端用户重新设计采购和库存策略，以确保服务的连续性和高品质的结果。

评估2025年美国关税对基因服务产业供应链、采购、创新路径和合规性的累积影响

2025年美国关税政策对客製化合成基因服务产业的供应链、采购惯例和营运决策产生了一系列累积影响。为因应这些影响，各机构正在重新评估筹资策略，实现供应商多元化，并探索近岸外包和地理多元化等方案，以减轻关税引发的成本调整带来的影响。同时，采购团队更加重视供应商合约的柔软性和紧急时应对计画，以确保关键试剂和设备的供应能够按计划进度进行。

详细的細項分析揭示了技术分类、产品系列、最终用户类型、应用领域和基因类型等方面的差异如何驱动需求模式和研发重点。

细分市场洞察清晰地揭示了价值集中领域，以及服务提供者应如何调整自身能力以满足客户需求。在技​​术层面，差异体现在DNA合成服务（例如从头基因合成和寡核苷酸服务）、基因建构技术（包括重组克隆和限制性内切酶克隆）以及不断扩展的基因编辑方法（以CRISPR-Cas9、TALEN和锌指平台为代表）之间。这些技术差异直接影响所需的产品支援和流程控制类型，进而影响客户在速度、精度和成本效益之间的优先顺序。

透过对美洲、欧洲、中东和非洲以及亚太地区差异的比较分析，明确竞争定位和区域优先事项。

美洲、欧洲、中东和非洲地区以及亚太地区的区域表现存在差异，这主要受不同管理体制、基础设施成熟度和客户生态系统的影响。在美洲，成熟的实验室网络和强大的转换路径将学术研究与商业开发紧密联繫起来，使供应商和终端用户都从中受益。这促进了新型基因编辑工具的快速应用，并带动了对可扩展合成和质体服务的高需求。同时，在欧洲、中东和非洲地区，对监管协调、合规准备和跨境合作的日益重视，推动了对能够展现严格品质系统和完善文件的供应商的需求。

从公司层面洞察领先和新兴供应商的竞争定位、伙伴关係模式、能力架构和创新重点。

企业级洞察着重于服务提供者如何建立能力、建立伙伴关係以及优先考虑投资，以保持竞争力。市场领导通常将深厚的合成和编辑平台技术专长与支援可重复结果和合规性的整合品质系统结合。同时，新兴服务供应商则透过灵活的营运模式、细分产品专精或策略联盟来脱颖而出，在无需大规模资本支出的情况下扩展服务范围。

为领导者提供建构韧性供应链、简化开发平臺、协调监管策略以及利用新兴平台的实用建议

为了将洞察转化为营运优势，领导者应采取一系列协调一致的行动。首先，透过供应商多元化、协商灵活的合约以及实施库存策略来增强供应链韧性，从而在保持成本竞争力的同时，最大限度地减少计划中断。其次，透过采用模组化工作流程、提高常规合成和克隆任务的自动化程度以及整合数据系统来简化开发平臺，从而在不影响品质的前提下加快设计-构建-测试週期。

调查方法：资料收集、专家访谈、混合方法分析、检验以及检验程序概述，以确保研究的严谨性和可重复性。

本研究采用多种方法，确保研究结果的稳健性和实用性。主要资料收集包括对学术界、生物技术公司、合约研究机构 (CRO) 和製药公司等各领域专家进行结构化访谈，以了解他们对营运挑战、采购重点和产品性能的第一手观点。次要资讯则透过对技术趋势的检验以及对已发布的监管指南和行业白皮书的仔细审查来补充访谈内容，从而为合规性考虑提供背景资讯。

对策略意义、风险考量和实际建议的最终综合，为参与客製化合成基因服务的相关人员提供了指南。

这项结论整合了报告的核心主题：技术进步、营运韧性、监管准备和策略差异化。这些维度共同构成了领导者在客製化合成基因服务领域中取得成功所必须遵循的策略框架。仅凭技术能力已不足以保证竞争优势；成功取决于将卓越的科学技术与供应链的灵活性和监管前瞻性相结合，以满足包括学术机构、生物技术公司、合约研究组织 (CRO) 和製药公司在内的多元化客户群的需求。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按产品分類的客製化合成基因服务市场

• CRISPR 引导 R​​NA
• Gblocks
• mRNA
• 寡核苷酸合成
• 质体DNA

9. 按技术分類的客製化合成基因服务市场

• DNA合成
  • 从头合成基因
  • 寡核苷酸服务
• 基因构建
  • 重组克隆
  • 限制性内切酶克隆
• 基因编辑

10. 按基因类型分類的客製化合成基因服务市场

• 引导RNA
• mRNA
• 质体载体
• 病毒载体

第十一章 按最终用户分類的客製化合成基因服务市场

• 学术机构
• 生技公司
• 合约研究机构
• 製药公司

12. 按应用分類的客製化合成基因服务市场

• 农业
• 诊断
• 调查
• 治疗

13. 各地区客製合成基因服务市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

14. 按群体分類的客製化合成基因服务市场

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

15. 各国客製合成基因服务市场

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

16. 美国客製化合成基因服务市场

第十七章：中国客製化合成基因服务市场

第十八章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Agilent Technologies Inc.
• Amyris Inc.
• Ansa Biotechnologies, Inc.
• ATUM
• Azenta Life Sciences
• Bio Basic Inc.
• Biomatik
• Bioneer
• Boster Biological Technology
• Codexis Inc.
• DNA Script SAS
• Elegen
• Eurofins Scientific
• Evonetix
• Gene Universal
• GenScript Biotech Corporation
• Ginkgo Bioworks Holdings, Inc.
• Integrated DNA Technologies Inc.
• Merck KGaA
• OriGene Technologies Inc.
• ProteoGenix Inc.
• Synbio Technologies
• Telesis Bio Inc.
• Thermo Fisher Scientific Inc.
• Twist Bioscience Corporation

The Custom Synthetic Genes Services Market was valued at USD 796.10 million in 2025 and is projected to grow to USD 883.19 million in 2026, with a CAGR of 11.72%, reaching USD 1,729.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 796.10 million
Estimated Year [2026]	USD 883.19 million
Forecast Year [2032]	USD 1,729.84 million
CAGR (%)	11.72%

Strategic introduction to custom synthetic genes services highlighting scientific foundations, market drivers, regulatory context, and strategic priorities

This executive introduction frames the custom synthetic genes services landscape by synthesizing the scientific, commercial, and regulatory context that underpins industry decision making. It situates the reader in a complex environment where advances in DNA synthesis, gene construction, and gene editing intersect with evolving procurement practices and heightened scrutiny across regulatory regimes. In doing so, the introduction emphasizes the dual nature of opportunity and operational risk that characterizes the current moment for providers, end users, and investors.

Moving from foundational science to strategic implications, the narrative highlights how technological capability, product breadth, and end-user specialization collectively influence service design and go-to-market approaches. The introduction also underscores the importance of integrated approaches that align R&D priorities, quality assurance, and supplier resilience. Ultimately, this section sets the analytical tone for the remainder of the document: it clarifies the critical questions leaders must answer, frames the competitive stakes, and outlines the decision levers available to organizations seeking to capture sustained value in the custom synthetic genes services domain.

How rapid technological advances, supply resilience measures, and shifting regulatory priorities are reshaping the custom synthetic genes ecosystem

The landscape for custom synthetic genes services is undergoing rapid, transformative shifts driven by converging technological breakthroughs and operational recalibrations. Advances in DNA synthesis, more precise gene construction techniques, and expanding gene editing toolkits are enabling shorter design cycles and more complex constructs, which in turn create new possibilities for both research and therapeutic development. In parallel, supply chain pressures and shifts in reagent sourcing have prompted service providers and end users to redesign procurement and inventory strategies to preserve continuity and maintain high-quality outputs.

Furthermore, regulatory adaptation continues to influence product development paths and commercial timelines. As regulatory frameworks evolve to address new technical capabilities and biosecurity considerations, organizations are responding by embedding regulatory strategy earlier in program design and by investing in compliance-ready manufacturing and documentation practices. Together, these dynamics are reshaping the competitive landscape: those who integrate scientific excellence with resilient operations and adaptive regulatory planning will differentiate their offerings and capture more enduring engagement from academic, clinical, and commercial customers.

Assessment of the cumulative impact of United States tariffs in 2025 on supply chains, procurement, innovation pathways, and compliance across gene services

The United States' tariff measures implemented in 2025 have produced a suite of cumulative impacts that ripple across supply chains, procurement practices, and operational decision making in the custom synthetic genes services sector. In response, organizations have revisited sourcing strategies, seeking greater diversity among suppliers and exploring nearshoring or regional distribution options to mitigate exposure to tariff-driven cost adjustments. At the same time, procurement teams are placing higher emphasis on supplier contractual flexibility and contingency planning, ensuring that critical reagent and instrument availability remains aligned with project timelines.

Moreover, the tariff environment has prompted many firms to reassess their innovation pathways, balancing the need to maintain R&D momentum with pressure to optimize unit economics. Regulatory compliance and documentation burdens have also become focal points, as changes in import/export classifications and customs scrutiny require enhanced traceability and more proactive regulatory engagement. Collectively, these shifts underscore the importance of operational agility: leaders who integrate tariff scenario planning into procurement and product development decisions will more effectively protect program continuity and sustain customer trust in a complex geopolitical context.

In-depth segmentation insights revealing how technology classifications, product portfolios, end-user types, application areas, and gene type distinctions drive demand patterns and R&D priorities

Insight into segmentation clarifies where value concentrates and how providers should align capabilities with customer needs. Based on technology, differentiation appears between DNA synthesis offerings such as de novo gene synthesis and oligonucleotide services, gene construction techniques including recombinant cloning and restriction cloning, and the expanding array of gene editing approaches led by CRISPR Cas9 alongside TALEN and Zinc Finger platforms. These technical distinctions directly shape the types of product support and process control required, and they influence which clients prioritize speed, precision, or cost efficiency.

When considered through the product lens, demand patterns vary across CRISPR guide RNA, Gblocks, mRNA, oligonucleotide synthesis, and plasmid DNA, with each product category attracting distinct operational requirements and customer adoption curves. End-user segmentation further clarifies adoption: academic institutions prioritize flexibility and publication timelines, biotech companies seek scalable, regulatory-aware solutions, contract research organizations demand consistent throughput and documentation, and pharmaceutical companies emphasize validated processes for downstream development. Across applications, agriculture, diagnostics, research, and therapeutics present divergent value propositions, while gene type distinctions among guide RNA, mRNA, plasmid vectors, and viral vectors determine handling, storage, and compliance workflows. Taken together, these layers of segmentation illuminate differentiated service models and indicate where investments in capability, quality systems, and customer engagement will deliver the greatest returns.

Insights contrasting dynamics across the Americas, Europe Middle East and Africa, and Asia-Pacific to clarify competitive positioning and regional priorities

Regional performance diverges across the Americas, Europe Middle East and Africa, and Asia-Pacific, driven by distinct regulatory regimes, infrastructure maturity, and customer ecosystems. In the Americas, suppliers and end users often benefit from well-established laboratory networks and strong translational pathways that link academic research with commercial development, which supports rapid adoption of novel gene editing tools and a high demand for scalable synthesis and plasmid services. In contrast, the Europe Middle East and Africa region frequently emphasizes regulatory harmonization, compliance readiness, and cross-border collaboration, which drives demand for providers that can demonstrate rigorous quality systems and robust documentation.

Meanwhile, Asia-Pacific markets display a broad spectrum of capability: some markets show rapid technological adoption and strong manufacturing capacity, while others remain in earlier stages of infrastructure buildup. This diversity creates opportunities for providers that can offer modular service packages and partnership models that address local needs. Across all regions, competitive differentiation accrues to organizations that tailor product portfolios and operational models to regional regulatory expectations, local supply chain constraints, and the specific demands of academic, clinical, and commercial customers.

Company-level insights evaluating competitive positioning, partnership models, capability stacks, and innovation priorities among leading and emerging providers

Company-level insights center on how providers configure capabilities, structure partnerships, and prioritize investments to remain competitive. Market leaders typically combine deep technical expertise in synthesis and editing platforms with integrated quality systems that support reproducible outputs and regulatory compliance. At the same time, emergent providers are differentiating through nimble operational models, niche product specialization, or strategic alliances that extend service breadth without requiring large capital outlays.

Partnership models and capability stacks matter: collaborations with reagent vendors, instrument manufacturers, and clinical development partners accelerate time-to-solution for customers, while internal investments in automation, informatics, and process standardization reduce variability and improve scalability. Innovation priorities also shape competitive positioning; firms that invest selectively in next-generation synthesis chemistry, automation, or informatics can expand addressable use cases. As a result, providers that combine technical depth with operational discipline and thoughtful partnership networks will sustain stronger customer relationships and capture opportunities across both discovery and translational workflows.

Actionable recommendations for leaders to build resilient supply chains, streamline R&D pipelines, align regulatory strategy, and leverage emerging platforms

Leaders should pursue a set of coordinated actions to translate insight into operational advantage. First, invest in supply chain resilience by diversifying supplier bases, negotiating flexible contracts, and implementing inventory strategies that reduce project disruption while preserving cost competitiveness. Second, streamline R&D pipelines by adopting modular workflows, increasing automation in routine synthesis and cloning tasks, and integrating data systems that accelerate design-build-test cycles without sacrificing quality.

Third, embed regulatory strategy early in program development by aligning documentation practices, validating critical processes, and maintaining active dialogue with regulatory stakeholders to anticipate compliance expectations. Fourth, prioritize customer-centric product design by tailoring offerings for academic, biotech, CRO, and pharmaceutical segments, and by providing clear pathways for scale-up from discovery to clinical application. Finally, pursue targeted technology investments that balance near-term operational returns with long-term differentiation. When implemented together, these recommendations enable organizations to reduce risk, accelerate innovation velocity, and capture sustained value across diverse customer segments.

Research methodology outlining data collection, expert interviews, mixed-method analysis, triangulation, and validation steps to ensure rigor and reproducibility

The research approach combined multiple methods to ensure robustness and practical relevance. Primary data collection included structured interviews with subject matter experts across academic, biotech, CRO, and pharmaceutical organizations to capture first-hand perspectives on operational challenges, procurement priorities, and product performance. Secondary sources complemented these interviews by validating technical trends, while careful document review of public regulatory guidance and industry white papers provided context for compliance considerations.

Analysis relied on mixed-method techniques that triangulated qualitative insights with quantitative supplier and product comparisons. Expert validation workshops tested preliminary conclusions and refined recommendations for applicability in varied operational contexts. Throughout, methodological rigor was maintained through transparent documentation of data sources, standardized interview guides, and reproducible analytical workflows, ensuring that the findings are actionable for decision makers seeking to align strategic plans with operational realities in custom synthetic genes services.

Final synthesis of strategic implications, risk considerations, and practical recommendations to guide stakeholders in custom synthetic genes services toward action

This conclusion synthesizes the report's central themes: technological advancement, operational resilience, regulatory alignment, and strategic differentiation. Together, these dimensions form the strategic architecture that leaders must navigate to succeed in custom synthetic genes services. Technological capability alone no longer guarantees competitive advantage; instead, success depends on integrating scientific excellence with supply chain agility and regulatory foresight to meet the divergent needs of academic, biotech, CRO, and pharmaceutical customers.

In practical terms, organizations that align product portfolios with end-user requirements, invest in quality and automation, and maintain adaptive procurement strategies will be better positioned to manage risk and accelerate value creation. The recommendations provided herein offer a framework for prioritizing investments and operational changes that improve responsiveness and sustain long-term competitiveness. In closing, the sector rewards holistic strategies that couple scientific innovation with disciplined execution and proactive regulatory engagement.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Custom Synthetic Genes Services Market, by Product

• 8.1. CRISPR Guide RNA
• 8.2. Gblocks
• 8.3. mRNA
• 8.4. Oligonucleotide Synthesis
• 8.5. Plasmid DNA

9. Custom Synthetic Genes Services Market, by Technology

• 9.1. DNA Synthesis
  • 9.1.1. De Novo Gene Synthesis
  • 9.1.2. Oligonucleotide Services
• 9.2. Gene Construction
  • 9.2.1. Recombinant Cloning
  • 9.2.2. Restriction Cloning
• 9.3. Gene Editing

10. Custom Synthetic Genes Services Market, by Gene Type

• 10.1. Guide RNA
• 10.2. mRNA
• 10.3. Plasmid Vectors
• 10.4. Viral Vectors

11. Custom Synthetic Genes Services Market, by End User

• 11.1. Academic Institutions
• 11.2. Biotech Companies
• 11.3. Contract Research Organizations
• 11.4. Pharmaceutical Companies

12. Custom Synthetic Genes Services Market, by Application

• 12.1. Agriculture
• 12.2. Diagnostics
• 12.3. Research
• 12.4. Therapeutics

13. Custom Synthetic Genes Services Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Custom Synthetic Genes Services Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Custom Synthetic Genes Services Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. United States Custom Synthetic Genes Services Market

17. China Custom Synthetic Genes Services Market

18. Competitive Landscape

• 18.1. Market Concentration Analysis, 2025
  • 18.1.1. Concentration Ratio (CR)
  • 18.1.2. Herfindahl Hirschman Index (HHI)
• 18.2. Recent Developments & Impact Analysis, 2025
• 18.3. Product Portfolio Analysis, 2025
• 18.4. Benchmarking Analysis, 2025
• 18.5. Agilent Technologies Inc.
• 18.6. Amyris Inc.
• 18.7. Ansa Biotechnologies, Inc.
• 18.8. ATUM
• 18.9. Azenta Life Sciences
• 18.10. Bio Basic Inc.
• 18.11. Biomatik
• 18.12. Bioneer
• 18.13. Boster Biological Technology
• 18.14. Codexis Inc.
• 18.15. DNA Script SAS
• 18.16. Elegen
• 18.17. Eurofins Scientific
• 18.18. Evonetix
• 18.19. Gene Universal
• 18.20. GenScript Biotech Corporation
• 18.21. Ginkgo Bioworks Holdings, Inc.
• 18.22. Integrated DNA Technologies Inc.
• 18.23. Merck KGaA
• 18.24. OriGene Technologies Inc.
• 18.25. ProteoGenix Inc.
• 18.26. Synbio Technologies
• 18.27. Telesis Bio Inc.
• 18.28. Thermo Fisher Scientific Inc.
• 18.29. Twist Bioscience Corporation

LIST OF FIGURES

• FIGURE 1. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 12. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 13. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CRISPR GUIDE RNA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CRISPR GUIDE RNA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CRISPR GUIDE RNA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GBLOCKS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GBLOCKS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GBLOCKS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID DNA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID DNA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DE NOVO GENE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DE NOVO GENE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DE NOVO GENE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SERVICES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RECOMBINANT CLONING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RECOMBINANT CLONING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RECOMBINANT CLONING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESTRICTION CLONING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESTRICTION CLONING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESTRICTION CLONING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GUIDE RNA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GUIDE RNA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GUIDE RNA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID VECTORS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID VECTORS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID VECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY VIRAL VECTORS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY VIRAL VECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 70. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 71. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 72. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 73. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 74. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 75. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
• TABLE 76. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 77. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 78. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 79. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 80. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 81. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 82. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 83. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 84. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 85. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 86. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 87. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 88. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 89. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 90. NORTH AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 91. NORTH AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 92. NORTH AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 93. NORTH AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 94. NORTH AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 95. NORTH AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 96. NORTH AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 97. NORTH AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 98. LATIN AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 99. LATIN AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 100. LATIN AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 101. LATIN AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 102. LATIN AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 103. LATIN AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 104. LATIN AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 105. LATIN AMERICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 114. EUROPE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 115. EUROPE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 116. EUROPE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 117. EUROPE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 118. EUROPE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 119. EUROPE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 120. EUROPE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 121. EUROPE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 122. MIDDLE EAST CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 123. MIDDLE EAST CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 124. MIDDLE EAST CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 125. MIDDLE EAST CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 126. MIDDLE EAST CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 127. MIDDLE EAST CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 128. MIDDLE EAST CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 129. MIDDLE EAST CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 130. AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 131. AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 132. AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 133. AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 134. AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 135. AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 136. AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 137. AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 138. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 139. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 140. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 141. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 142. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 143. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 144. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 145. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 146. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 147. ASEAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 148. ASEAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 149. ASEAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 150. ASEAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 151. ASEAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 152. ASEAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 153. ASEAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 154. ASEAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 155. GCC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 156. GCC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 157. GCC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 158. GCC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 159. GCC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 160. GCC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 161. GCC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 162. GCC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 163. EUROPEAN UNION CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 164. EUROPEAN UNION CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 165. EUROPEAN UNION CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 166. EUROPEAN UNION CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 167. EUROPEAN UNION CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 168. EUROPEAN UNION CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 169. EUROPEAN UNION CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 170. EUROPEAN UNION CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 171. BRICS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 172. BRICS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 173. BRICS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 174. BRICS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 175. BRICS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 176. BRICS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 177. BRICS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 178. BRICS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 179. G7 CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 180. G7 CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 181. G7 CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 182. G7 CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 183. G7 CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 184. G7 CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 185. G7 CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 186. G7 CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 187. NATO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 188. NATO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 189. NATO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 190. NATO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 191. NATO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 192. NATO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 193. NATO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 194. NATO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 195. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 196. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 197. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 198. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 199. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 200. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 201. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 202. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 203. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 204. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 205. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 206. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 207. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2032 (USD MILLION)
• TABLE 208. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 209. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2032 (USD MILLION)
• TABLE 210. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 211. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)